FIELD: medicine. SUBSTANCE: method involves carrying out hypoxic procedure combined with chemiluminescence of blood neutrophils both Luminal-dependent and induced by opsonized Zymozan. Blood neutrophils chemiluminescence characteristics are determined and blood neutrophils chemiluminescence characteristics ratios are calculated before and after the first hypoxic procedure. The value being greater than 0.9 or less than 0.6, positive or negative therapeutic effectiveness at the end of medical treatment is predicted, respectively. EFFECT: enhanced accuracy of the method; enhanced effectiveness of treatment. 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING HYPOXIC THERAPY EFFECTIVENESS IN PATIENTS SUFFERING FROM BRONCHO-OBSTRUCTION SYNDROME | 1996 |
|
RU2098816C1 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN ACUTE RHINOSINUSITIS | 2010 |
|
RU2438134C1 |
METHOD FOR ASSESSMENT OF FUNCTIONAL ABILITY OF PHAGOCYTES | 2011 |
|
RU2445626C1 |
METHOD FOR DETERMINING INDIVIDUAL'S SENSITIVITY TO OXIDATIVE STRESS | 2012 |
|
RU2508545C1 |
METHOD OF PREDICTING DEVELOPMENT OF GENERALISED COMPLICATIONS IN CASE OF ACUTE DESTRUCTIVE PANCREATITIS | 2008 |
|
RU2393771C1 |
METHOD FOR DETERMINING HYPOXIA RESISTANCE OF LABORATORY ANIMALS BY LEVEL OF PRODUCTION OF PRO-INFLAMMATORY AND ANTI-INFLAMMATORY CYTOKINES BY BLOOD CELLS | 2023 |
|
RU2821545C1 |
METHOD FOR DETERMINING THE ACTIVITY OF RECEPTORS OF HUMAN NEUTROPHILS | 0 |
|
SU1686372A1 |
METHOD FOR DETERMINING LOW RESISTANCE TO HYPOXIA OF LABORATORY ANIMALS IN VITRO BY LEVEL OF SPONTANEOUS AND STIMULATED PRODUCTION OF IL-1β BY BLOOD CELLS | 2023 |
|
RU2821643C1 |
METHOD OF LIFE-TIME EXCLUSION OF TUBERCULOSIS | 2008 |
|
RU2389020C2 |
METHOD FOR DETERMINING LEUKOCYTARY GENERATION OF ACTIVE OXYGEN FORMS | 1992 |
|
RU2042949C1 |
Authors
Dates
1997-12-10—Published
1996-05-13—Filed